Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02255383 · ClinicalTrials.gov registry record · NA
Persona Total Knee Arthroplasty Outcomes Study
A NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.
- Active
- Registry status
- NA
- Development phase
- 737
- Enrollment target
- 14
- Study locations
NCT02255383: Active NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.
NCT02255383 is a NA study of Rheumatoid Arthritis and Osteoarthritis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 737 participants, below the 4,687-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (84% lower). The trial reports 14 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02255383, a NA study of Rheumatoid Arthritis and Osteoarthritis, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 737 participants
- Enrollment target
- 14
- Study locations
Study Summary
The primary objective of this study is to obtain implant survivorship and clinical outcomes data for commercially available Persona fixed bearing knee implants used in total knee arthroplasty. The assessment will include implant survivorship and clinical performance.
Primary Outcome
Knee Society Score
Conditions Studied
Interventions
- DEVICE Zimmer Persona Total Knee System
Study Locations (14)
Colorado
- Colorado Joint Replacement - Denver
- Orthopaedic & Spine Center of the Rockies - Fort Collins
- Denver-Vail Orthopedics - Parker
North Carolina
- UNC Department of Orthopaedics - Chapel Hill
- OrthoCarolina - Charlotte
- Raleigh Orthopaedic Clinic - Raleigh
Ohio
- Lindner Research Center - Cincinnati
- SportsMedicine Grant & Orthopaedic Associates - Columbus
Illinois
- Rockford Orthopedic Associates - Rockford
Indiana
- Henry County Orthopedics and Sports Medicine - New Castle
Pennsylvania
- University of Pennsylvania - Philadelphia
Tennessee
- Tennessee Orthopaedic Foundation for Education and Research - Knoxville
Texas
- Texas Tech University Health Sciences Center - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 737 participants |
| Start Date | 2014-07 |
| Est. Completion | 2027-12 |
| Phase | NA |
What the registry record for NCT02255383 still lists
NCT02255383 is an interventional study that assigns participants to a tested intervention. The registered 737 participants enrollment target is mid-sized for trials with a published cap, below the 4,687-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (84% lower).
The record links to 7 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Zimmer Persona Total Knee System is the first listed.
NCT02255383 lists 14 locations in 9 states (Colorado, North Carolina, Ohio).
Frequently Asked Questions
What is clinical trial NCT02255383 about?
NCT02255383 is a clinical study titled "Persona Total Knee Arthroplasty Outcomes Study". The primary objective of this study is to obtain implant survivorship and clinical outcomes data for commercially available Persona fixed bearing knee implants used in total knee arthroplasty. The assessment will include implant survivorship and clinical performance.
What is the current status of trial NCT02255383?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 737 participants. The study started on 2014-07. Estimated completion is 2027-12.
What conditions does trial NCT02255383 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Knee Pain Chronic, Traumatic Arthritis, Polyarthritis.
What interventions are being tested in trial NCT02255383?
The interventions under investigation include: Zimmer Persona Total Knee System (DEVICE).
Who is sponsoring clinical trial NCT02255383?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02255383 being conducted?
This trial has 14 study locations across Colorado, Illinois, Indiana, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02255383's enrollment target sits among peer trials
737 32nd of 197 higher than 166 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
RECRUITING · NA
-
Improving Hypertension Control in Rheumatoid Arthritis
RECRUITING · NA
-
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05796141 · 736 participants · NA
Becoming United in Lifestyle Decisions
- NCT03723928 · 739 participants · NA
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
- NCT05947851 · 735 participants · Phase 3
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
- NCT05999084 · 735 participants
Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia